Condition
Ischemia, Mesenteric
Total Trials
2
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Smofkabiven
Research Leaders
11 sponsors active, led by Erasmus Medical Center
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Recruiting1
Active Not Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Smofkabiven1
Active Sponsors
- Erasmus Medical Center1
- Copenhagen University Hospital, Hvidovre1
- Holbaek Sygehus1
- Nordsjaellands Hospital1
- Bispebjerg Hospital1
Top Investigators
Copenhagen University Hospital at Herlev
Related Conditions
- Bowel Obstruction1
- Laparotomy1
- Major Emergency Abdominal Surgery1
- Chronic Mesenteric Ischemia1